{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T18:17:32Z","timestamp":1780597052829,"version":"3.54.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"1-2","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.jconrel.2013.03.032","type":"journal-article","created":{"date-parts":[[2013,4,6]],"date-time":"2013-04-06T13:30:58Z","timestamp":1365255058000},"page":"150-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Development and evaluation of novel solid nanodispersion system for oral delivery of poorly water-soluble drugs"],"prefix":"10.1016","volume":"169","author":[{"given":"Paul","family":"Nkansah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Antipas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manthena","family":"Varma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Rotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Rago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"El-Kattan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Litchfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jconrel.2013.03.032_bb0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/0192623307310946","article-title":"Drug nanoparticles: formulating poorly water-soluble compounds","volume":"36","author":"Merisko-Liversidge","year":"2008","journal-title":"Toxicol. Pathol."},{"issue":"1","key":"10.1016\/j.jconrel.2013.03.032_bb0010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","article-title":"Drug-like properties and the causes of poor solubility and poor permeability","volume":"44","author":"Christopher","year":"2000","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2013.03.032_bb0015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0168-3659(02)00049-4","article-title":"Microemulsion formulation for enhanced absorption of poorly soluble drugs: I. Prescription design","volume":"81","author":"Kawakami","year":"2002","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2013.03.032_bb0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0378-5173(95)00122-Y","article-title":"Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs","volume":"125","author":"Liversidge","year":"1995","journal-title":"Int. J. Pharm."},{"issue":"Supplement 2(0)","key":"10.1016\/j.jconrel.2013.03.032_bb0025","first-page":"S93","article-title":"Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and self-microemulsifying drug delivery systems","volume":"11","author":"Colin","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2013.03.032_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejpb.2005.05.009","article-title":"Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation","volume":"62","author":"Keck","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"23","key":"10.1016\/j.jconrel.2013.03.032_bb0035","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1002\/1521-3773(20011203)40:23<4330::AID-ANIE4330>3.0.CO;2-W","article-title":"Organic nanoparticles in the aqueous phase\u2014theory, experiment, and use","volume":"40","author":"Horn","year":"2001","journal-title":"Angew. Chem. Int. Ed."},{"issue":"2","key":"10.1016\/j.jconrel.2013.03.032_bb0040","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0378-5173(97)00311-6","article-title":"Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique","volume":"160","author":"Muller","year":"1998","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.jconrel.2013.03.032_bb0045","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s11095-010-0200-0","article-title":"Effect of crystal size on the dissolution and oral absorption of nitrendipine in rats","volume":"27","author":"Xia","year":"2010","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.jconrel.2013.03.032_bb0050","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jconrel.2010.10.034","article-title":"Nanonization of megestrol acetate by laser fragmentation in aqueous milieu","volume":"149","author":"Sylvestre","year":"2011","journal-title":"J. Control. Release"},{"issue":"1-2","key":"10.1016\/j.jconrel.2013.03.032_bb0055","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jconrel.2005.11.013","article-title":"Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs","volume":"111","author":"Jinno","year":"2006","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2013.03.032_bb0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0939-6411(00)00091-6","article-title":"Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards","volume":"50","author":"Lobenberg","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2013.03.032_bb0065","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijpharm.2011.05.073","article-title":"Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder","volume":"419","author":"Ghosh","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.jconrel.2013.03.032_bb0070","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.2042-7158.2010.01022.x","article-title":"Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods","volume":"62","author":"Peltonen","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"issue":"12","key":"10.1016\/j.jconrel.2013.03.032_bb0075","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1211\/jpp.61.12.0001","article-title":"Review: physical chemistry of solid dispersions","volume":"61","author":"Janssens","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"issue":"3","key":"10.1016\/j.jconrel.2013.03.032_bb0080","first-page":"295","article-title":"Nanocrystal technology, drug delivery and clinical applications","volume":"3","author":"Junghanns","year":"2008","journal-title":"Int. J. Nanomedicine"},{"issue":"8","key":"10.1016\/j.jconrel.2013.03.032_bb0085","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jps.2600540810","article-title":"Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures I \u2014 theoretical considerations and discussion of literature","volume":"54","author":"Goldberg","year":"1965","journal-title":"J. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.jconrel.2013.03.032_bb0090","first-page":"788","article-title":"Physicochemical study of drug binary-systems.3. tolbutamide-urea and tolbutamide\u2013mannitol systems","volume":"30","author":"El-Banna","year":"1975","journal-title":"Pharmazie"},{"issue":"12","key":"10.1016\/j.jconrel.2013.03.032_bb0095","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3109\/03639045.2011.587428","article-title":"The use of spray-drying to enhance celecoxib solubility","volume":"37","author":"Fouad","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"2","key":"10.1016\/j.jconrel.2013.03.032_bb0100","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/jps.20522","article-title":"Characterization of a novel polymorphic form of celecoxib","volume":"95","author":"Lu","year":"2006","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2013.03.032_bb0105","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.ejpb.2008.02.001","article-title":"Thermodynamic behavior of glassy state of structurally related compounds","volume":"69","author":"Kaushal","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.jconrel.2013.03.032_bb0110","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.micromeso.2011.07.007","article-title":"MCM-41 for furosemide dissolution improvement","volume":"147","author":"Ambrogi","year":"2012","journal-title":"Microporous Mesoporous Mater."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2013.03.032_bb0115","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijpharm.2008.04.025","article-title":"Prediction of oral absorption in humans by experimental immobilized artificial membrane chromatography indices and physicochemical descriptors","volume":"360","author":"Kotecha","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"3\u20134","key":"10.1016\/j.jconrel.2013.03.032_bb0120","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ejps.2009.04.009","article-title":"Temperature and solvent effects in the solubility of some pharmaceutical compounds: measurements and modeling","volume":"37","author":"Mota","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.jconrel.2013.03.032_bb0125","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1021\/mp200103h","article-title":"pH-Sensitive Interaction of HMG-CoA Reductase Inhibitors (Statins) with Organic Anion Transporting Polypeptide 2B1","volume":"8","author":"Varma","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2013.03.032_bb0130","series-title":"Pharmacokinetics","author":"Gibaldi","year":"1982"},{"issue":"11","key":"10.1016\/j.jconrel.2013.03.032_bb0135","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1211\/0022357001777487","article-title":"Gastrointestinal first-pass effect of furosemide in rats","volume":"52","author":"Kim","year":"2000","journal-title":"J. Pharm. Pharmacol."},{"issue":"4","key":"10.1016\/j.jconrel.2013.03.032_bb0140","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1248\/cpb.60.459","article-title":"Polymer combination increased both physical stability and oral absorption of solid dispersions containing a low glass transition temperature drug: physicochemical characterization and in vivo study","volume":"60","author":"Sakurai","year":"2012","journal-title":"Chem. Pharm. Bull."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2013.03.032_bb0145","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijpharm.2011.10.053","article-title":"Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes","volume":"422","author":"Yan","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/j.jconrel.2013.03.032_bb0150","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1248\/cpb.c12-00034","article-title":"Use of the co-grinding method to enhance the dissolution behavior of a poorly water-soluble drug: generation of solvent-free drug-polymer solid dispersions","volume":"60","author":"Yang","year":"2012","journal-title":"Chem. Pharm. Bull."},{"issue":"8","key":"10.1016\/j.jconrel.2013.03.032_bb0155","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3109\/03639045.2011.633264","article-title":"To evaluate the effect of addition of an anionic surfactant on solid dispersion using model drug indomethacin","volume":"38","author":"Dave","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2013.03.032_bb0160","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s13318-011-0059-4","article-title":"In vitro\u2013in situ permeability and dissolution of fexofenadine with kinetic modeling in the presence of sodium dodecyl sulfate","volume":"37","author":"Gundogdu","year":"2012","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.jconrel.2013.03.032_bb0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(01)00097-7","article-title":"Crystalline solids","volume":"48","author":"Vippagunta","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7","key":"10.1016\/j.jconrel.2013.03.032_bb0170","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","article-title":"Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update","volume":"25","author":"Jantratid","year":"2008","journal-title":"Pharm. Res."},{"issue":"10","key":"10.1016\/j.jconrel.2013.03.032_bb0175","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1007\/s11095-008-9630-3","article-title":"A modified approach to predict dissolution and absorption of polydisperse powders","volume":"25","author":"Butcher","year":"2008","journal-title":"Pharm. Res."},{"issue":"6","key":"10.1016\/j.jconrel.2013.03.032_bb0180","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1023\/A:1022678505433","article-title":"A new understanding of the relationship between solubility and particle size","volume":"27","author":"Wu","year":"1998","journal-title":"J. Solution Chem."},{"issue":"3","key":"10.1016\/j.jconrel.2013.03.032_bb0185","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s11095-011-0579-2","article-title":"Prediction of nonlinear intestinal absorption of CYP3A4 and P-glycoprotein substrates from their in vitro Km values","volume":"29","author":"Tachibana","year":"2012","journal-title":"Pharm. Res."},{"issue":"11","key":"10.1016\/j.jconrel.2013.03.032_bb0190","doi-asserted-by":"crossref","first-page":"532","DOI":"10.5414\/CPP38532","article-title":"Similarity in the linear and non-linear oral absorption of drugs between human and rat","volume":"38","author":"Chiou","year":"2000","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.jconrel.2013.03.032_bb0195","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5414\/CPP39093","article-title":"A comprehensive account on the role of efflux transporters in the gastrointestinal absorption of 13 commonly used substrate drugs in humans","volume":"39","author":"Chiou","year":"2001","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.jconrel.2013.03.032_bb0200","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF01059061","article-title":"Evaluation of potential causes for the incomplete bioavailability of furosemide \u2014 gastric 1st-pass metabolism","volume":"11","author":"Lee","year":"1983","journal-title":"J. Pharmacokinet. Biopharm."},{"issue":"11","key":"10.1016\/j.jconrel.2013.03.032_bb0205","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1023\/A:1011981317451","article-title":"Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats","volume":"15","author":"Chiou","year":"1998","journal-title":"Pharm. Res."},{"issue":"12","key":"10.1016\/j.jconrel.2013.03.032_bb0210","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1023\/A:1013358126640","article-title":"Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein","volume":"18","author":"Adachi","year":"2001","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.jconrel.2013.03.032_bb0215","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1124\/dmd.107.017434","article-title":"In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system","volume":"36","author":"Feng","year":"2008","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.jconrel.2013.03.032_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01061772","article-title":"Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition","volume":"21","author":"Kim","year":"1993","journal-title":"J. Pharmacokinet. Biopharm."},{"issue":"2","key":"10.1016\/j.jconrel.2013.03.032_bb0225","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3109\/10837450.2012.710239","article-title":"Enhanced dissolution performance of curcumin with the use of supersaturatable formulations","volume":"18","author":"Gosangari","year":"2013","journal-title":"Pharm. Dev. Technol."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2013.03.032_bb0230","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ijpharm.2012.11.012","article-title":"Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique","volume":"441","author":"Marasini","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2013.03.032_bb0235","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.apt.2012.06.010","article-title":"Processing and formulation of drug nanoparticles by ternary cogrinding with methacrylic copolymer and sucrose fatty acid esters","volume":"24","author":"Hida","year":"2013","journal-title":"Adv. Powder Technol."},{"issue":"8","key":"10.1016\/j.jconrel.2013.03.032_bb0240","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1158\/0008-5472.CAN-10-3118","article-title":"High plasma levels and effective lymphatic uptake of docetaxel in an orally available nanotransporter formulation","volume":"71","author":"Nassar","year":"2011","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.jconrel.2013.03.032_bb0245","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1211\/jpp.62.03.0006","article-title":"Bioavailability of lycopene in the rat: the role of intestinal lymphatic transport","volume":"62","author":"Faisal","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"issue":"12","key":"10.1016\/j.jconrel.2013.03.032_bb0250","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1023\/A:1012155124489","article-title":"Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond","volume":"14","author":"Artursson","year":"1997","journal-title":"Pharm. Res."},{"issue":"6","key":"10.1016\/j.jconrel.2013.03.032_bb0255","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/jps.22030","article-title":"Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Furosemide","volume":"99","author":"Granero","year":"2010","journal-title":"J. Pharm. Sci."},{"issue":"11","key":"10.1016\/j.jconrel.2013.03.032_bb0260","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/jps.1127","article-title":"Effect of common excipients on Caco-2 transport of low-permeability drugs","volume":"90","author":"Rege","year":"2001","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2013.03.032_bb0265","article-title":"Martindale: The Complete Drug Reference","year":"2009"},{"issue":"5","key":"10.1016\/j.jconrel.2013.03.032_bb0270","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/BF00556898","article-title":"Implications of intraindividual variability in bioavailability studies of furosemide","volume":"27","author":"Grahnen","year":"1984","journal-title":"Eur. J. Clin. Pharmacol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365913001752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365913001752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T03:58:50Z","timestamp":1539748730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365913001752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":54,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0168365913001752"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.03.032","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and evaluation of novel solid nanodispersion system for oral delivery of poorly water-soluble drugs","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.03.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}